After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Cerus Corp is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Medical Devices industry. The current market capitalization of Cerus Corp is $414.91M. A total of 1.77 million shares were traded on the day, compared to an average of 1.46M shares.
In the most recent transaction, Jensen Chrystal sold 55,000 shares of CERS for 1.70 per share on Nov 24 ’25. After the transaction, the Chief Legal Officer now owns 728,294 company shares. In a previous transaction on Nov 24 ’25, CHRYSTAL NIKOLE JENSEN bought 55,000 shares at 1.70 per share.
Among the insiders who bought shares, Gregory Dean A. acquired of 25,000 shares on Aug 25 ’25 at a per-share price of $1.25. This resulted in the Director holding 86,725 shares of CERS after the transaction. In another insider transaction, Jensen Chrystal sold 30,075 shares at $1.45 per share on Mar 14 ’25. Company shares held by the Chief Legal Officer now total 783,294.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, CERS has a high of $2.25 and a low of $1.12.
As of this writing, CERS has an earnings estimate of -$0.0 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of $0.0 per share and a lower estimate of -$0.01. The company reported an EPS of -$0.01 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CERS’s latest balance sheet shows that the firm has $129.36M in Cash & Short Term Investments as of fiscal 2021. There were $87.59M in debt and $78.56M in liabilities at the time. Its Book Value Per Share was $0.32, while its Total Shareholder’s Equity was $85.62M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CERS is Buy with a score of 4.20.
